You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes

Article info

Article menu

Download PDFPDF

XML
Pathophysiology/Complications
Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes

Authors

  • Caroline K Kramer Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Bernard Zinman Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Haysook Choi Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Ravi Retnakaran Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ravi Retnakaran; rretnakaran{at}mtsinai.on.ca
View Full Text

Citation

Kramer CK, Zinman B, Choi H, et al
Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes
BMJ Open Diabetes Research and Care 2016;4:e000270. doi: 10.1136/bmjdrc-2016-000270

Publication history

  • Received May 12, 2016
  • Revised June 14, 2016
  • Accepted July 14, 2016
  • First published August 1, 2016.
Online issue publication 
May 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/